Navigation Links
Newly Published EPA RCRA Method 6800 Supports AIT Technology
Date:2/20/2008

Calibration-less Elemental & Speciated Analysis Brings Unprecedented

Accuracy

PITTSBURGH, Feb. 20 /PRNewswire/ -- Applied Isotope Technologies ("AIT") announced today, that the EPA Method 6800 has been published in January 2008 edition of the Federal Register as a part of the methods section of a broad set of US environmental statutes known as RCRA (Resource Conservation and Recovery Act). This updated version of the method includes a long list of samples and data, including soil, water, tissue, yeast, hair, industrial material, etc. AIT sells products that support Method 6800.

Matt Pamuku, CEO and President of AIT said, "Method 6800 now joins a group of critical testing methods for the US and the world to follow, so that we can help protect our environment and health of its inhabitants. This powerful method is one of the most accurate and fail-proof tests that has ever been invented." Mr. Pamuku continued, "As a singular source of products, AIT is proud to have supported Method 6800 in the past, as it went through ten years of scientific scrutiny as a draft EPA method."

The EPA RCRA Method 6800 provides a powerful method that incorporates an advanced version of the venerable isotope dilution technique, accepted as one of the most reliable analytical tools in the analytical chemistry field. The unique approach detailed in the Method 6800 provides the ability, for the first time, to obtain results that can withstand legal challenge in the courts. This is a critical and much valued attribute for many regulatory agencies, such as the Environmental Protection Agency, Centers for Disease Control and Federal Drug Administration, and communities affected by industrial pollution.

In addition to legal defensibility, the Method 6800 is also uniquely helpful in identifying sources of errors in other methods. Over the past decade, a number of peer-reviewed publications have utilized this method to better understand and optimize the performance of other analytical techniques. Mr. Pamuku commented, "The analysts who adopted the Method 6800 are always delighted that such performance can be achieved without calibration curves which require long, frequent, and often expensive and frustrating work."

AIT develops and sells Method 6800 compliant products that can be used in a special class of instruments called mass spectrometers that are widely used in almost every analytical laboratory involved in environment-related analytical work. AIT's mercury products, for example, helps accurately identify and measure highly toxic mercury species, such as methylmercury that can be found in some of the popular food sources, such as fish, as a consequence of industrial pollution. AIT products facilitate detection at less than 10 parts per trillion levels without compromising accuracy which is particularly an important consideration for supertoxin analysis. http://www.SIDMS.com


'/>"/>
SOURCE Applied Isotope Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
2. Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions
3. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
4. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
5. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Vasogens Research Published in European Journal of Neuroscience
8. The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
9. International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development
10. NIST team develops novel method for nanostructured polymer thin films
11. Nanofabrication method paves way for new optical devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... DIEGO , Dec. 8, 2016  Renova™ ... for congestive heart failure and type 2 diabetes, ... for a novel adeno-associated virus (AAV) vector developed ... , M.D., Ph.D., at Stanford University. The company ... its paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... , December 8, 2016 ... expanded its customisable SureSeq™ NGS panel range with the launch ... fast and cost-effective study of variants in familial hypercholesterolemia (FH). ... variation (CNV) detection on a single small panel and allows ... content. This includes all exons for LDLR , ...
(Date:12/8/2016)... ... December 08, 2016 , ... This CAST literature review ... biotech crops. The authors focus on the economic effects in countries that are major ... new biotech crops and the resultant risk of low level presence (LLP) puts large ...
(Date:12/8/2016)... SEOUL, South Korea , Dec. 8, 2016 /PRNewswire/ ... completed a $21 billion KRW (US $18.9M) Series A ... Management, Kolon Investment, G.N. Tech Venture and SNU Bio ... by Eutilex to 30.5 billion KRW (US $27.7M) since ... will help Eutilex to bolster the development and commercialization ...
Breaking Biology Technology:
(Date:12/7/2016)... 7, 2016   Avanade is helping Williams ... teams in history, exploit biometric data in order to ... maintain the competitive edge against their rivals after their ... Avanade has worked with Williams during the 2016 ... data (heart rate, breathing rate, temperature and peak acceleration) ...
(Date:12/5/2016)... Dec. 5, 2016  The Office of Justice ... "Can CT Scans Enhance or Replace Medico Legal ... of supporting or replacing forensic autopsies with postmortem ... In response to recommendations made by ... using CT scans as a potential component of ...
(Date:11/29/2016)... BioDirection, a privately held medical device company developing novel ... concussion and other traumatic brain injury (TBI), announced today ... the U.S. Food and Drug Administration (FDA) to review ... meeting company representatives reviewed plans for clinical development of ... a planned pilot trial. "We are ...
Breaking Biology News(10 mins):